BioScience Health Innovations (BHIC) EBIAT (2020 - 2025)
Historic EBIAT for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to -$8782.0.
- BioScience Health Innovations' EBIAT fell 11562.58% to -$8782.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $885677.0, marking a year-over-year increase of 219052.42%. This contributed to the annual value of $87000.0 for FY2024, which is 13459.24% up from last year.
- Latest data reveals that BioScience Health Innovations reported EBIAT of -$8782.0 as of Q3 2025, which was down 11562.58% from $457704.0 recorded in Q2 2025.
- BioScience Health Innovations' 5-year EBIAT high stood at $457704.0 for Q2 2025, and its period low was -$85262.0 during Q2 2023.
- In the last 5 years, BioScience Health Innovations' EBIAT had a median value of -$12668.0 in 2021 and averaged $30477.0.
- As far as peak fluctuations go, BioScience Health Innovations' EBIAT plummeted by 139217.82% in 2022, and later soared by 89953.17% in 2025.
- BioScience Health Innovations' EBIAT (Quarter) stood at -$14089.0 in 2021, then tumbled by 105.25% to -$28917.0 in 2022, then plummeted by 32.71% to -$38376.0 in 2023, then soared by 125.95% to $9957.0 in 2024, then plummeted by 188.2% to -$8782.0 in 2025.
- Its EBIAT stands at -$8782.0 for Q3 2025, versus $457704.0 for Q2 2025 and $426798.0 for Q1 2025.